Men whose prostate cancer comes back after surgery are more likely to survive if, along with the usual radiation, they also take drugs to block male hormones.
The finding, published Wednesday in The New England Journal of Medicine, comes from a long-running study that experts say will help clarify treatment for many patients.
{iframe}https://www.nytimes.com/2017/02/01/health/prostate-cancer-hormone-blockers.html?emc=edit_th_20170202&nl=todaysheadlines&nlid=34889205&_r=0{/iframe}